OPEN END TURBO LONG - MERCK & CO. Stock

Certificat

DE000MD9LHH8

Market Closed - Bid/Ask 12:09:15 2024-06-27 EDT After market 15:03:05
2.62 EUR -10.88% Intraday chart for OPEN END TURBO LONG - MERCK & CO. 2.635 +0.57%
Current month+28.95%
1 month+8.49%
Date Price Change
24-06-27 2.62 -10.88%
24-06-26 2.94 -3.29%
24-06-25 3.04 +0.66%
24-06-24 3.02 +9.03%
24-06-21 2.77 +1.47%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 12:09 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD9LHH
ISINDE000MD9LHH8
Date issued 2022-10-20
Strike 100.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.15
Lowest since issue 0.37
Spread 0.01
Spread %0.38%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus